immunology Archives -

News/ News/ News/ Oncology/ R&D

Merck pledges revamp of R&D to drive productivity

Phil Taylor immunology, Merck KGaA, neurology, Oncology, R&D, strategy 0 Comment

Germany’s Merck KGaA has said it needs to double the productivity of its R&D operations, with the aim

Merck pledges revamp of R&D to drive productivity

https://pharmaphorum.com/news/merck-pledges-revamp-of-rd-to-drive-productivity/

News/ News/ News/ R&D/ Sales and Marketing

AbbVie acquires DJS for $255m cash, fortifies immunology pipeline

Nicole Raleigh AbbVie, acuqisition, DJS Antibodies, immunology, M&A, UK research 0 Comment

The acquisition of DJS Antibodies, a privately-held UK-based biotechnology company dedicated to discovering and developing antibody medicines that

AbbVie acquires DJS for $255m cash, fortifies immunology pipeline

https://pharmaphorum.com/news/abbvie-acquires-djs-for-255m-cash-fortifies-immunology-pipeline/

Science background with molecules and atoms

Digital/ News/ News/ Oncology/ R&D

Odyssey Therapeutics $168 million Series B financing oversubscribed

Nicole Raleigh AI, General Catalyst, immunology, Innovation, machine learning, Odyssey Therapeutics, Oncology, Series B financing 0 Comment

Biotech company Odyssey Therapeutics, Inc. has announced a $168 million Series B financing, led by global venture capital

Odyssey Therapeutics $168 million Series B financing oversubscribed

https://pharmaphorum.com/news/odyssey-therapeutics-168-million-series-b-financing-oversubscribed/

Close up of lab assistant in uniform, with mask and rubber gloves holding test tube with blood sample while sitting on chair and typing on laptop. Selective focus on test tubes.

Digital/ Press Releases/ R&D/ Views & Analysis/ Views and analysis

The future of AI drug discovery & development in immunology and GPCR research

Nicole Raleigh AI drug discovery, autoimmune disease, clinical trials, GPCR, immunology, Molecular Biology, precision health, Sosei Heptares, Verily 0 Comment

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research

The future of AI drug discovery & development in immunology and GPCR research

https://pharmaphorum.com/digital/the-future-of-ai-drug-discovery-development-in-immunology-and-gpcr-research/

Insights/ Oncology/ Views and analysis

A history of blood cancer treatment

Eloise McLennan A history of..., blood cancer, bone marrow transplant, breakthroughs, CAR-T therapies, cell therapies, chemotherapy, cord blood, immunology, leukaemia, lymphoma, melanoma, Non-Hodgkins Lymphoma 0 Comment

Despite being one of the most common forms of cancer, awareness of blood cancer pales in comparison to

A history of blood cancer treatment

https://pharmaphorum.com/oncology/a-history-of-blood-cancer-treatment/

Events/ Events/ R&D

Welcome to the 6th Complement-based Drug Development Summit 2022

Hollie Bulfin autoimmune, Complement, immunology, inflammatory disease, Rare diseases 0 Comment

Decipher Complement Pathway Intricacies, Validate Pathway Activation Assays & Discover Next-Generation Complement-Targeted Approaches that are Transforming Patient Outcomes

Welcome to the 6th Complement-based Drug Development Summit 2022

https://pharmaphorum.com/events/welcome-to-the-6th-complement-based-drug-development-summit-2022/

News/ News/ Sales and Marketing

Dupixent drives Sanofi to hike its full-year profit forecasts

Phil Taylor Dupixent, Financial, immunology, Sanofi 0 Comment

Dupixent’s march towards becoming one of the world’s top-selling medicines continued at a healthy lick in the second

Dupixent drives Sanofi to hike its full-year profit forecasts

https://pharmaphorum.com/news/dupixent-drives-sanofi-to-hike-its-full-year-profit-forecasts/

News/ News/ R&D

AbbVie cuts Alzheimer’s alliance with Alector in half

Phil Taylor AbbVie, Alector, Alzheimer's disease, immunology, neurology, partnering 0 Comment

AbbVie is pulling out of its collaboration with Alector on the development of Alzheimer’s disease candidate AL003, which

AbbVie cuts Alzheimer’s alliance with Alector in half

https://pharmaphorum.com/news/abbvie-cuts-alzheimers-alliance-with-alector-in-half/

News/ News/ R&D

Biotech founder arrested in US amid murder-for-hire investigation

Phil Taylor criminal investigation, Enochian Biosciences, immunology, Legal, Oncology, Serhat Gümrükcü 0 Comment

The co-founder of Los Angeles biotech Enochian Biosciences has been arrested in connection with a federal investigation into

Biotech founder arrested in US amid murder-for-hire investigation

https://pharmaphorum.com/news/biotech-founder-arrested-in-us-amid-murder-for-hire-investigation/

Trending

immunology

Login